Pharmacokinetics of vancomycin in patients with severely impaired renal function

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 2, 1996, Pages 71-75

  Gonzalez Martin G ^a   Acuna, V ^a   Perez C ^a   Labarca, J ^a   Guevara, A ^a   Tagle, R ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Chronic renal failure; Hemodialysis; Pharmacokinetics; Vancomycin

Indexed keywords

CREATININE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; COMPUTER PROGRAM; CREATININE CLEARANCE; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEMODIALYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; VANCOMYCIN;

EID: 0030033812     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Alpert G, Campos JM, Harris MC, Preblub SK, Plotkin SA 1984 Vancomycin dosage in pediatrics reconsidered. Am J Dis Child 138: 20-22
2. Banner W, Ray CG 1984 Vancomycin in perspective. Am J Dis Child 138, 14-16
3. Barcenas CG, Fuller TJ, Elms J, Cohen R, White MG 1976 Staphylococcal sepsis in patients with chronic hemodialysis regimen. Arch Intern Med 136: 1131-1134
4. Bierman MH, Needham-Walker CA, Hammeke N, Egan JD 1980 Vancomycin therapy for serious staphylococcus infections in chronic hemodyalisis patient. J Dialysis 4: 179-184
5. Brown N, Ho DHW, Fong KL, Bogerd L, Maksymiuk A et al 1983 Effects of hepatic function on vancomycin clinical pharmacology. Antimicrob Agents Chemother 23: 603-609
6. Burnett DA, Barak AJ, Tuma DJ et al 1976 Altered elimination of antipyrine in patients with acute viral hepatitis. Gut 17: 341-344
7. Cockcroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
8. Cook FV, Farrar FV, Farrar WE Jr 1978 Vancomycin revisited. Ann Intern Med 88: 813-818
9. Cunha BA, Quintiliani R, Deglin JM et at 1981 Pharmacokinetics of vancomycin in anuria. Rev Infect Dis 3: S269-272
10. Dangerfield HG, Hewitt WC, Monzon OT et al 1960 Clinical use of vancomycin. Antimicrob Agents Ann: 428-438
11. Eykyn S, Phillips I, Evans J 1970 Vancomycin for staphylococcal shunt site infections in patients on regular hemodialysis. Br Med J 3: 80-82
12. Gibson TP, Lucas SV, Nelson HA et al 1978 Hemoperfusion removal of digoxin from dogs. J Lab Clin Med 91: 673-682
13. Hook EW, Johnson WD 1978 Vancomycin therapy of bacterial endocarditis. Am J Med 65: 411-415
14. Krogstand DJ, Moellering RC, Greenblatt DJ 1980 Single-dose kinetics intravenous vancomycin. J Clin Pharmacol 20: 197-201
15. Lam FY, Lindner A, Plorde J et al 1981 Pharmacokinetics of vancomycin in chronic renal failure. Kidney Int 19: 152
16. Lindholm DD, Murray JS 1966 Persistence of vancomycin in the blood during renal failure and its treatment by hemodyalisis N Engl J Med 274: 1047-1051
17. Linneman CC, McKee E, Laver MC 1978 Staphylococcal infections in a hemodialysis unit. Am J Med Sci 276: 67
18. Masur H, Francioli P, Ruddy M, Murray HW 1983 Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia. Clin Nephrol 20: 85-88
19. Matzke GR, McGory RW, Halstenson CE, Keane WF 1984 Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother 25: 433-437
20. Moellering LC, Krogstad DJ. Greenblatt DJ 1981 Vancomycin therapy in patients with impaired renal failure: A nomogram for dosage. Ann Intern Med 94: 343-346
21. Montiel J, Acuna G 1993 Guia de terapia antimicrobiana. Ed Mediter-ránea, Santiago, pp 20-21
22. Nielsen HE, Hansen HE, Korsager B, Skov PE 1975 Renal excretion of vancomycin in kidney disease Acta Med Scand 197: 261-264
23. Ristuccia PA, Ristuccia AM, Bidanset JH et al 1984 Comparison of bioassay, high performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum. Ther Drug Monit 6: 238-242
24. Rotschafer JC, Crossley K, Zaske DE, Mead K, Sawchuk RJ et al 1982 Pharmacokinetics of vancomycin observations in 28 patients and dosage recommendations Antimicrob Agents Chemother 22, 391-394
25. Rowlands M, Tozer TN 1989 Clinical pharmacokinetics. Concepts and application (2nd ed). Lea and Febiger, Philadelphia, pp 17-32
26. Schaad UB, Nelson JB, McCracken GH 1981 Pharmacology of vancomycin for Staphylococcus infections in children. Reviews of infections disease 3 (Suppl): S282-S289
27. Shargel L. Yu ABC 1985 Applied biopharmaceutics and pharmacokinetics (2nd ed). Appleton-Century-Crofts, Norwalk. pp 324-325
28. Statistical Consultant Inc. PCNONLIN and NON-LIN 84 1986 Software for the statistical analysis of non linear model. The American Statistician 40: 52
29. Salem NG, Blevin RB, Maztke GR 1984 Clearance of vancomycin by hemodialysis. 30th Annual Am Soc for Artificial Internal Organs, Washington DC
30. Tan CC, Lee HS, Ti TY, Lee EJC 1990 Pharmacokinetics of intravenous vancomycin in patients with end-stage renal failure. Ther Drug Monit 12, 29-34